Relationship between soluble transferrin receptors in serum and membrane-bound transferrin receptors

Acta Haematologica

Volumn 99, Issue 1, 1998, Pages 8-11

  Kuiper Kramer, Ellen P A ^a   Coenen, Jules L L M ^a   Huisman, Carla M S ^a   Abbes, André ^a   Van Raan, Jan ^a   Van Eijk, Henk G ^b  

^a Sophia Hospital   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anaemia; Anaemia of chronic disease; Erythroblasts; Flow cytometry; Iron deficiency; Myelodysplastic syndrome; Transferrin receptor

Indexed keywords

TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; MYELODYSPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM;

ANEMIA; BONE MARROW CELLS; CHRONIC DISEASE; ERYTHROBLASTS; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMANS; IRON; MYELODYSPLASTIC SYNDROMES; RECEPTORS, TRANSFERRIN;

EID: 0031975527     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040707     Document Type: Article

References (16)

1. Brock JH, Halliday JW, Pippard MJ, Powell LW: Iron Metabolism in Health and Disease. London, Saunders, 1994.
2. Cook JD, Skikne BS, Baynes RD: Serum transferrin receptor. Annu Rev Med 1993;44:63-74.
3. Kohgo Y, Niitsu Y, Kondo H, Kato J, Tsushima N, Saski K, Hirayama M, Numata T, Nishisato T, Urushizaki I: Serum transferrin receptor as a new index of erythropoiesis. Blood 1987;70:1955-1958.
4. Kuiper-Kramer EPA, Huisman CMS, Van der Molen-Sinke J, Abbes A, Van Eijk HG: The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency. Acta Haematol 1997;97:127-131.
5. Rutledge EA, Root BJ, Lucas JJ, Enns CA: Elimination of the O-linked glycosylation site at Thr 104 results in the generation of a soluble human transferrin receptor. Blood 1994;83: 580-586.
6. Chitambar CR, Loebel AL, Nobie NA: Shedding of transferrin receptor from rat reticulocytes during maturation in vitro: Soluble transferrin receptor is derived from receptor shed in vesicles. Blood 1991;78:2444-2450.
7. Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 1990;75:1870-1876.
8. Punnonen K, Irjala K, Rajamaki A: Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 1994;40:774-776.
9. Petterson T, Kivivuori SM, Siimes MA: Is serum transferrin receptor useful for detecting iron-deficiency in anemic patients with chronic inflammatory diseases? Br J Rheumatol 1994; 33:740-744.
10. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD: Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1993; 119:385-390.
11. Bowen DT, Culligan D, Beguin Y, Kendall R, Willis N: Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia 1993;8:151-155.
12. Kuiper-Kramer EPA, Huisman CMS, Van Raan J, Van Eijk HG: Analytical and clinical implications of soluble transferrin receptors in serum. Eur J Clin Chem Clin Biochem 1996; 34:645-649.
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51: 189-199.
14. Shintani N, Kohgo Y, Kato J, Kondo H, Fujikawa K, Miyazaki E, Niitsu Y: Expression and extracellular release of transferrin receptors during peripheral erythroid progenitor cell differentiation in liquid culture. Blood 1994;83: 1209-1215.
15. Nielsen OJ, Anderen LS, Hansen NRE, Hansen TM: Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis. Scand J Lab Invest 1994;54:75-82.
16. Feelders RA, Vreugdenhil G, Van Dijk JP, Swaak AJ, Van Eijk HG: Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis. Am J Hematol 1993;43:200-204.